Evaluation of the Effectiveness of Health Literacy Education Given to Women by Teach-Back Method

January 12, 2026 updated by: Fatma Dünmez, Istanbul University - Cerrahpasa

Evaluation of the Effectiveness of Health Literacy Education Given to Women by Teach-Back Method: Randomized Controlled Trial

This study aims to enhance women's health literacy levels and to examine the effectiveness of the teach-back teaching technique in improving women's health literacy. The research was designed as a randomized controlled study. In addition, this study aims to answer the question of whether health literacy education delivered using the teach-back method is effective in improving women's health literacy levels. Within the scope of the study, participants in the experimental group will receive health literacy education using the teach-back technique, while the control group will receive standard care. Data will be collected using a questionnaire method.

Study Overview

Status

Not yet recruiting

Detailed Description

This study aims to enhance women's health literacy levels and to examine the effectiveness of the teach-back teaching technique in improving women's health literacy. Women aged between 18 and 65 years with a General Health Questionnaire-12 score below 4 will be included in the study. To determine the participants' socio-demographic and health characteristics, the "Personal Information Form" will be used; to assess general health, the "General Health Questionnaire-12" will be applied; to measure health literacy levels, the "Türkiye Health Literacy Scale-32 (TSOY-32)" will be utilized; and to assess self-efficacy, the "General Self-Efficacy Scale" will be employed. Additionally, the "Training Effectiveness Evaluation Form" will be used to evaluate the effectiveness of the education provided to the experimental group. The study will consist of a total of 74 participants, with 37 in the experimental group and 37 in the control group. Verbal and written consent will be obtained from participants who agree to take part in the study, and the participants will be assigned to groups accordingly. The experimental group will receive face-to-face health literacy education using the teach-back method in six sessions, each lasting 45 minutes per week. The control group will receive standard care.

Study Type

Interventional

Enrollment (Estimated)

74

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Istanbul, Turkey (Türkiye), 34500
        • Istanbul University- Cerrahpasa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Women aged between 18 and 65 years
  • Those with a General Health Questionnaire-12 score below 4

Exclusion Criteria:

  • Illiterate women
  • Male individuals
  • Those with communication difficulties
  • Healthcare professionals (physicians, midwives, nurses, etc.)
  • Emergency patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Teach-back

The experimental group will receive face-to-face health literacy education using the teach-back method in six sessions, each lasting 45 minutes per week.

The training will be provided by the researcher on a one-to-one basis. Health literacy education will be delivered using the teach-back method. After each session, participants will be asked to repeat what they have learned in their own words. The researcher will assess how well the participants have understood the topic. Any misunderstandings will be identified and corrected. During this process, participants will also have the opportunity to ask questions. Additional information will be provided if necessary until participants can accurately repeat the expected knowledge. The module will be considered complete once the participants have correctly expressed the information and understood the topic. The following week, the next module will begin, and this process will continue until all six modules are completed.

The experimental group will receive face-to-face health literacy education using the teach-back method in six sessions, each lasting 45 minutes per week.

The training will be provided by the researcher on a one-to-one basis. Health literacy education will be delivered using the teach-back method. After each session, participants will be asked to repeat what they have learned in their own words. The researcher will assess how well the participants have understood the topic. Any misunderstandings will be identified and corrected. During this process, participants will also have the opportunity to ask questions. Additional information will be provided if necessary until participants can accurately repeat the expected knowledge. The module will be considered complete once the participants have correctly expressed the information and understood the topic. The following week, the next module will begin, and this process will continue until all six modules are completed.

Other: Control Group
The control group will receive standard care.
The control group will receive standard care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health literacy
Time Frame: Measurements will be taken at baseline, immediately after the training (week 6), and one month after the training (week 10).

The Turkey Health Literacy Scale-32 will be used to measure health literacy levels. It is a scale consisting of 32 questions. The total score takes values between 0 and 50. 0 indicates the lowest health literacy level, and 50 indicates the highest health literacy level.

According to the scoring system below, health literacy is defined as follows:

a score of 0-25 indicates inadequate health literacy; a score of >25-33 indicates problematic-limited health literacy; a score of >33-42 indicates adequate health literacy; and a score of >42-50 indicates excellent health literacy.

Measurements will be taken at baseline, immediately after the training (week 6), and one month after the training (week 10).
The General Self-Efficacy Scale
Time Frame: Measurements will be taken at baseline, immediately after the training (week 6), and one month after the training (week 10).
The General Self-Efficacy Scale will be used to measure the participants' self-efficacy levels. The scale is a 5-point Likert-type instrument consisting of three subdimensions and 17 items. The subdimensions are Initiation (9 items), Persistence (5 items), and Maintenance Effort-Determination (3 items). The total scale score ranges from 17 to 85, with higher total scores indicating a higher level of self-efficacy belief.
Measurements will be taken at baseline, immediately after the training (week 6), and one month after the training (week 10).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

July 1, 2027

Study Registration Dates

First Submitted

December 22, 2025

First Submitted That Met QC Criteria

December 22, 2025

First Posted (Estimated)

January 6, 2026

Study Record Updates

Last Update Posted (Actual)

January 14, 2026

Last Update Submitted That Met QC Criteria

January 12, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Literacy

Clinical Trials on teach-back

Subscribe